LNSR
LNSR
NASDAQ · Health Care

Lensar Inc

$5.96
+0.09 (+1.53%)
As of Mar 31, 10:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
50.45M
Net Income
-29,615,939
Gross Margin
48.3%
Profit Margin
-58.7%
Rev Growth
+15.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 48.3% 48.3% 57.4% 57.4%
Operating Margin -19.9% -17.9% 10.3% 10.3%
Profit Margin -58.7% -55.8% 9.6% 8.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 50.45M 43.57M 55.38M 51.89M
Gross Profit 24.38M 21.06M 31.77M 29.77M
Operating Income -10,059,462 -7,818,909 5.73M 5.35M
Net Income -29,615,939 -23,019,557 5.32M 4.60M
Gross Margin 48.3% 48.3% 57.4% 57.4%
Operating Margin -19.9% -17.9% 10.3% 10.3%
Profit Margin -58.7% -55.8% 9.6% 8.9%
Rev Growth +15.8% +15.8% +8.2% -2.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 15.51M 16.29M
Total Equity 70.64M 78.05M
D/E Ratio 0.22 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -29,323,744 -24,058,689 9.24M 7.86M
Free Cash Flow 5.04M 4.51M